K Mayer

Summary

Country: Germany

Publications

  1. Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, et al. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry. Thromb Haemost. 2014;112:1190-7 pubmed publisher
    ..These findings, however, need confirmation from specifically designed randomised studies in this high-risk cohort of patients. ..
  2. Mayer K, Bernlochner I, Braun S, Schulz S, Orban M, Morath T, et al. Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry. J Am Coll Cardiol. 2014;64:863-71 pubmed publisher
    ..Present data are in support of the addition of HAPR to a panel of prognostic biomarkers in PCI-treated patients. ..
  3. Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, et al. The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry. Thromb Res. 2015;136:87-93 pubmed publisher
    ..The numerically higher rate of major bleedings and the clustering of STs in the TH cohort warrant further investigation. ..
  4. Mayer K, Schulz S, Bernlochner I, Morath T, Braun S, Hausleiter J, et al. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Thromb Haemost. 2014;112:342-51 pubmed publisher
    ..The issue of personalised antiplatelet treatment warrants further investigation in randomized and well-controlled clinical trials. ..

Collaborators